These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9228542)

  • 1. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Immunopharmacology; 1997 Jun; 36(2-3):167-72. PubMed ID: 9228542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent, long-acting bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new generation of bradykinin antagonists.
    Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of bradykinin receptors in a human osteoblastic cell line.
    Brechter AB; Lerner UH
    Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in bradykinin receptor-mediated responses of the airways.
    Ellis KM; Fozard JR
    Auton Autacoid Pharmacol; 2002 Feb; 22(1):3-16. PubMed ID: 12423422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation.
    Banik RK; Kozaki Y; Sato J; Gera L; Mizumura K
    J Neurophysiol; 2001 Dec; 86(6):2727-35. PubMed ID: 11731532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
    Drube S; Liebmann C
    Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
    Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L
    Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147
    [No Abstract]   [Full Text] [Related]  

  • 10. Two B1 and B2 bradykinin receptor antagonists fail to inhibit the Ca2+ response elicited by bradykinin in human skin fibroblasts.
    Cassano G; Susca F; Lippe C; Guanti G
    Gen Pharmacol; 1999 Feb; 32(2):239-44. PubMed ID: 10188626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
    Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
    Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bradykinin antagonist: current status and perspective].
    Hirayama Y; Kayakiri H
    Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):45-53. PubMed ID: 11862756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B2 receptor antagonist peptide Hoe 140.
    Kennedy KJ; Orwig KS; Dix TA; Christopher J; Jaffa AA
    J Pept Res; 2002 Apr; 59(4):139-48. PubMed ID: 11972749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.
    Amblard M; Daffix I; Bedos P; Bergé G; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Dodey P; Martinez J
    J Med Chem; 1999 Oct; 42(20):4185-92. PubMed ID: 10514288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single position in the third transmembrane domains of the human B1 and B2 bradykinin receptors is adjacent to and discriminates between the C-terminal residues of subtype-selective ligands.
    Fathy DB; Mathis SA; Leeb T; Leeb-Lundberg LM
    J Biol Chem; 1998 May; 273(20):12210-8. PubMed ID: 9575169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.
    Amblard M; Bedos P; Olivier C; Daffix I; Luccarini JM; Dodey P; Pruneau D; Paquet JL; Martinez J
    J Med Chem; 2000 Jun; 43(12):2382-6. PubMed ID: 10882364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional ligands of the bradykinin B
    Marceau F; Bawolak MT; Fortin JP; Morissette G; Roy C; Bachelard H; Gera L; Charest-Morin X
    Peptides; 2018 Jul; 105():37-50. PubMed ID: 29802875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S; Lecci A; Maggi CA
    Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.